NCT06249724

Brief Summary

This study will apply low-intensity transcranial focused ultrasound to dorsal root ganglia in patients with chronic neuropathic pain. The target will be validated using magnetic resonance imaging. The stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial. The level of pain will be evaluated using the Numerical Rating Scale (NSR-11) and the Patient-Reported Outcomes Measurement Information System (PROMIS) numerical rating scales of pain.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

February 10, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2024

Completed
Last Updated

May 22, 2025

Status Verified

April 1, 2025

Enrollment Period

Same day

First QC Date

January 31, 2024

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain intensity: momentary change

    Numerical Rating Scale (NRS-11) of pain. NRS-11 is a subjective measure in which individuals rate their pain on an eleven-point numerical scale. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).

    During the intervention, and every day thereafter, for 7 days

  • Pain intensity: subjective state

    PROMIS scale of pain intensity. Scores range from 1 (no pain) to 5 (severe pain). A lower score indicates a better treatment outcome.

    Immediately after the intervention, and every day thereafter, for 7 days

Study Arms (2)

Active stimulation

ACTIVE COMPARATOR

Low-intensity focused ultrasound stimulation of dorsal root ganglion involved in pain conduction

Device: Active stimulation using low-frequency ultrasonic transducer

Sham stimulation

SHAM COMPARATOR

Zero-intensity focused ultrasound stimulation of dorsal root ganglion involved in pain conduction

Device: Sham stimulation using low-frequency ultrasonic transducer

Interventions

The ultrasonic transducer delivers focused low-intensity ultrasound stimulation

Active stimulation

The ultrasonic transducer delivers focused zero-intensity ultrasound stimulation

Sham stimulation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary diagnosis of chronic pain
  • Moderate-to-severe chronic pain lasting at least 2 months
  • Stated willingness to comply with all study procedures and avoid changes to current treatments (medications, physical therapy, cognitive behavioral therapy) for the duration of the study
  • For females of reproductive potential: negative pregnancy test or use of highly effective contraception for at least 1 month prior to baseline; agreement to use such a method throughout the study
  • Capacity to provide informed consent; provision of a signed and dated consent form

You may not qualify if:

  • Poorly managed general medical condition
  • Pregnant or breast feeding
  • Implanted device in the back
  • Lifetime history of a serious suicide attempt
  • Clinically inappropriate for participation in the study as determined by the study team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah

Salt Lake City, Utah, 84112, United States

Location

MeSH Terms

Conditions

NeuralgiaChronic Pain

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jan Kubanek, PhD

    University of Utah

    PRINCIPAL INVESTIGATOR
  • Daniel Odell, MD

    University of Utah

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 8, 2024

Study Start

February 10, 2024

Primary Completion

February 10, 2024

Study Completion

February 10, 2024

Last Updated

May 22, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations